Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients

NCT02376296 · clinicaltrials.gov ↗

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: docetaxel
OTHER: Blood draws

Sponsor

Saladax Biomedical, Inc.

Collaborators

[object Object]